|
SPOP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.064800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.021240E-01 |
| Normal-vs-Stage2 |
2.644600E-01 |
| Normal-vs-Stage3 |
9.608400E-02 |
| Normal-vs-Stage4 |
1.247760E-01 |
| Stage1-vs-Stage2 |
8.761400E-01 |
| Stage1-vs-Stage3 |
5.622800E-01 |
| Stage1-vs-Stage4 |
3.672600E-01 |
| Stage2-vs-Stage3 |
7.471400E-01 |
| Stage2-vs-Stage4 |
4.528000E-01 |
| Stage3-vs-Stage4 |
6.008600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.895600E-03 |
| Normal-vs-AfricanAmerican |
1.999990E-01 |
| Normal-vs-Asian |
2.811600E-01 |
| Caucasian-vs-AfricanAmerican |
3.316000E-01 |
| Caucasian-vs-Asian |
5.542000E-01 |
| AfricanAmerican-vs-Asian |
3.036600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.073700E-02 |
| Normal-vs-Female |
2.119400E-03 |
| Male-vs-Female |
7.823800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.196200E-01 |
| Normal-vs-Extreme_Weight |
7.785600E-02 |
| Normal-vs-Obese |
2.536400E-02 |
| Normal-vs-Extreme_Obese |
8.159200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.588000E-01 |
| Normal_Weight-vs-Obese |
2.552000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.263800E-01 |
| Extreme_Weight-vs-Obese |
6.687600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.090600E-01 |
| Obese-vs-Extreme_Obese |
4.288000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.039500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.776700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.404800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.198800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.994580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.096600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.444600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.318600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.908410E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.410800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.579900E-04 |
| Normal-VS-Type2 PRCC |
9.429800E-01 |
| Normal-VS-KIRP CIMP |
4.422000E-02 |
| Normal-VS-Unclassified PRCC |
8.887600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.475310E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.564600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.813200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.139900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.646100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.313400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.133000E-01 |
| Normal-vs-N1 |
2.407800E-02 |
| Normal-vs-N2 |
6.293900E-02 |
| N0-vs-N1 |
5.325900E-02 |
| N0-vs-N2 |
3.011400E-01 |
| N1-vs-N2 |
8.805600E-01 |
|
|
